Valuation Opus Genetics, Inc.

Stocks

Real-time Estimate Cboe BZX Other stock markets 12:14:24 2026-07-24 EDT			5-day change	1st Jan Change
2.895 ^USD	-0.86%		-11.93%	+43.28%

07-09	Opus Genetics Provides Update On OPGx-BEST1 Program With Detailed Timeline For OPGx-BEST1 Results	CI
07-06	Opus Genetics Unlocks Key Milestone With US FDA Alignment on OPGx-LCA5 Phase 3, Wedbush Says	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	64.53	73.45	68.14	37.57	138.6	241.1	-	-
Change	-	13.82%	-7.23%	-44.87%	268.99%	73.93%	-	-
Enterprise Value (EV)	64.53	73.45	68.14	37.57	138.6	241.1	241.1	241.1
Change	-	13.82%	-7.23%	-44.87%	268.99%	73.93%	0%	0%
P/E	-0.98x	4.06x	-6.54x	-0.55x	-2.51x	-2.72x	-3.85x	-6.83x
PBR	-	-	-	-	-	-	-	-
PEG	-	-0x	0x	-0x	0x	-0.1x	0.1x	0.2x
Capitalization / Revenue	110x	1.84x	3.58x	3.42x	9.76x	15.9x	16.3x	5.34x
EV / Revenue	0x	0x	0x	0x	0x	15.9x	16.3x	5.34x
EV / EBITDA	-	-	-	-	-	-	-	-
EV / EBIT	-0x	0x	-0x	-0x	-0x	-4.66x	-4.11x	-6.14x
EV / FCF	-0x	-	-0x	-0x	-0x	-4.42x	-4.37x	-61.3x
FCF Yield	-30%	-	-1.63%	-68.1%	-25.4%	-22.6%	-22.9%	-1.63%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	-3.82	0.87	-0.46	-2.15	-0.8	-1.072	-0.7594	-0.4273
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	0.589	39.85	19.05	10.99	14.2	15.18	14.83	45.11
EBITDA	-20.79	-	-	-	-	-	-	-
EBIT ¹	-22.7	18.23	-10.56	-62.07	-38.6	-51.79	-58.62	-39.27
Net income ¹	-56.69	17.89	-9.986	-57.53	-49.59	-94.49	-67.77	-45.77
Net Debt	-	-	-	-	-	-	-	-
Reference price ²	3.730	3.530	3.010	1.190	2.010	2.920	2.920	2.920
Nbr of stocks (in thousands)	17,300	20,807	22,638	31,568	68,964	82,566	-	-
Announcement Date	3/24/22	3/30/23	3/8/24	3/31/25	3/10/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
OPUS GENETICS, INC.	-2.72x	-	-	-	241M
ELI LILLY AND COMPANY	35.39x	12.58x	26.43x	0.57%	1,057B
JOHNSON & JOHNSON	27.79x	6.35x	17.58x	2.07%	624B
ABBVIE INC.	33.47x	7.59x	15.59x	2.68%	454B
ROCHE HOLDING AG	20.98x	4.63x	11.4x	2.86%	341B
NOVARTIS AG	21.62x	5.7x	13.97x	2.82%	297B
ASTRAZENECA PLC	21.08x	4.45x	12.3x	1.98%	262B
NOVO NORDISK A/S	14.13x	5.26x	10.83x	3.54%	215B
AMGEN INC.	24.37x	6.41x	11.32x	2.71%	201B
GILEAD SCIENCES, INC.	-47.14x	5.65x	31.2x	2.52%	162B
Average	14.90x	6.51x	16.74x	2.42%	361.42B
Weighted average by Cap.	24.72x	7.88x	18.52x	1.98%